This archive contains links to the full-text of all issues of Clin Mol Hepatol.
![]() |
First decision
07 Days
Publication after acceptance
04 Days
*Last 12 months
Viewed By 11947 |
Epidemiology of metabolic dysfunction-associated steatotic liver disease |
Viewed By 7478 |
MAFLD: How is it different from NAFLD? |
Viewed By 6568 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Viewed By 5734 |
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment |
Viewed By 5352 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 355 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Cited By 331 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 223 |
MAFLD: How is it different from NAFLD? |
Cited By 114 |
Non-alcoholic fatty liver disease: Definition and subtypes |
Cited By 110 |
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis |